Neurocrine Biosciences Inc. (NBIX)
NASDAQ · Healthcare
Neurocrine Biosciences Inc. Cash Flow 2009–2025
| Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | Dec 2013 | Dec 2012 | Dec 2011 | Dec 2010 | Dec 2009 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | |||||||||||||||
| Operating Cash Flow | 782.7M | 595.4M | 389.9M | 339.4M | 256.5M | 228.5M | 147.0M | 101.4M | -94.3M | -106.2M | -29.6M | -35.3M | -698,000 | 49.9M | -53.1M |
| Depreciation & Amort. | — | — | — | — | — | — | — | 4.0M | 2.4M | 1.5M | 671,000 | 657,000 | 694,000 | 1.4M | 3.2M |
| Investing Activities | |||||||||||||||
| Capital Expenditure | 34.0M | 38.2M | 28.3M | 16.5M | 23.4M | 10.9M | 14.7M | 24.8M | 6.9M | 4.1M | 545,000 | 971,000 | 750,000 | 315,000 | 35,000 |
| Free Cash Flow | 748.7M | 557.2M | 361.6M | 322.9M | 233.1M | 217.6M | 132.3M | 76.6M | -101.3M | -110.3M | -30.2M | -36.3M | -1.4M | 49.6M | -53.1M |
| Financing Activities | |||||||||||||||
| Dividends Paid | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Stock Buybacks | 167.7M | 300.0M | 0 | 0 | — | — | — | — | — | — | — | — | — | — | — |
Neurocrine Biosciences Inc. Cash Flow — FAQ
Neurocrine Biosciences Inc. (NBIX) cash flow over the last 17 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see NBIX's cash flow history?
The chart and table above show Neurocrine Biosciences Inc.'s cash flow by year and by quarter, including the growth rate.